HealthAsianet Newsable
Gates MRI, Serum Institute ink deal to make potential new TB vaccine
in5points
Gates Medical Research Institute and Serum Institute of India signed an agreement to manufacture the M72/AS01E TB vaccine candidate.
M72/AS01E is currently in Phase 3 trials and could be the first new TB vaccine in over a century.
The partnership aims to ensure scalable production for high-burden countries if the vaccine is approved.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically